Literature DB >> 1774128

Fluoxetine and orgasmic sexual experiences.

P L Morris1.   

Abstract

The purpose of this article to describe a unique potential side effect of fluoxetine. A case report of a patient with post stroke depression treated with fluoxetine is presented. Fluoxetine was associated temporally with frequent short episodes of sexual excitement described by the patient as feeling like an orgasm. The relationship was dose dependent. Serotonergic medications, like fluoxetine, may induce sexual stimulation as a side effect. The mechanism for this effect is unclear but patients with organic brain disease may be at higher risk for this complication.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1774128     DOI: 10.2190/JUNJ-XXQ2-ER17-96LR

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  5 in total

1.  Sertraline-induced hypersexuality in a patient taking bupropion.

Authors:  Piyush Das; Abhishek Rai; Amit Chopra; Vijay Dewan
Journal:  Prim Care Companion CNS Disord       Date:  2012-04-05

2.  Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.

Authors:  R Ramasubbu
Journal:  J Psychiatry Neurosci       Date:  1999-01       Impact factor: 6.186

Review 3.  Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.

Authors:  M G Harris; P Benfield
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

4.  SSRI-Induced Hypersexuality.

Authors:  Shiwen Yuan; Courtney E Deban
Journal:  Am J Psychiatry Resid J       Date:  2021-03-12

5.  Treatment of multiple distressing spontaneous orgasms with citalopram and their re-emergence following discontinuation of prolonged use of citalopram in an adult female survivor of child sexual abuse.

Authors:  Adarsh Vohra
Journal:  Indian J Psychiatry       Date:  2012-10       Impact factor: 1.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.